85 related articles for article (PubMed ID: 24742244)
1. S100A4 is an independent prognostic factor for patients with lung cancer: a meta-analysis.
Bai H; Qian JL; Han BH
Genet Test Mol Biomarkers; 2014 May; 18(5):371-4. PubMed ID: 24742244
[TBL] [Abstract][Full Text] [Related]
2. S100A4 expression and prognosis of gastric cancer: a meta-analysis.
Wang Y; Zhou LB; Li XH
Genet Mol Res; 2014 Dec; 13(4):10398-403. PubMed ID: 25511023
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
4. Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis.
Huang S; Zheng J; Huang Y; Song L; Yin Y; Ou D; He S; Chen X; Ouyang X
Dis Markers; 2016; 2016():8137378. PubMed ID: 26903691
[TBL] [Abstract][Full Text] [Related]
5. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
6. Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma.
Tsuna M; Kageyama S; Fukuoka J; Kitano H; Doki Y; Tezuka H; Yasuda H
Anticancer Res; 2009 Jul; 29(7):2547-54. PubMed ID: 19596927
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma.
Shah CH; Viktorsson K; Kanter L; Sherif A; Asmundsson J; Rosenblatt R; Lewensohn R; Ullén A
Urol Oncol; 2014 Nov; 32(8):1215-24. PubMed ID: 24880461
[TBL] [Abstract][Full Text] [Related]
8. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
9. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
Qi RX; Xu XY
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
11. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis.
Ling Z; Li R
Int J Biol Markers; 2014 Jun; 29(2):e99-e111. PubMed ID: 24242292
[TBL] [Abstract][Full Text] [Related]
13. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma.
Chong HI; Lee JH; Yoon MS; Suh DS; Kim K; Kim JY; Choi KU
Oncol Rep; 2014 Jun; 31(6):2701-7. PubMed ID: 24756855
[TBL] [Abstract][Full Text] [Related]
17. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
18. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.
Oida Y; Yamazaki H; Tobita K; Mukai M; Ohtani Y; Miyazaki N; Abe Y; Imaizumi T; Makuuchi H; Ueyama Y; Nakamura M
Oncol Rep; 2006 Sep; 16(3):457-63. PubMed ID: 16865243
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the epithelial to mesenchymal transition markers S100A4, vimentin and Snail1 in gastroesophageal junction tumors.
Mirza A; Foster L; Valentine H; Welch I; West CM; Pritchard S
Dis Esophagus; 2014 Jul; 27(5):485-92. PubMed ID: 23082947
[TBL] [Abstract][Full Text] [Related]
20. Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.
Rud AK; Lund-Iversen M; Berge G; Brustugun OT; Solberg SK; Mælandsmo GM; Boye K
BMC Cancer; 2012 Aug; 12():333. PubMed ID: 22853000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
